الانتقال إلى المحتوى الرئيسي

كتابة تعليق

مراجعة PREreview لCombination Therapy in Hypertension: Renin-Angiotensin-Aldosterone System Inhibitor with a Diuretic or Calcium Channel Blocker

نُشرت
DOI
10.5281/zenodo.17259940
الترخيص
CC BY 4.0

This paper’s goal was to comparatively analysis the most frequently used combination: RAAS inhibitor with diuretics or a calcium channel blocker. This is a very good study because combination therapy is better than one therapy. The topic is relevant and addresses significant public health issues. However, the abstract talks mainly about the background and does not balance with other sections, such as methods, results, and conclusions.

Methods

I am not sure what methods were used to arrive at the presented findings, as this is not clear in the manuscript. I would appreciate it if the author could clarify this clearly, providing details on sampling methods, inclusion, and exclusion criteria. This will help clarify other sections of the manuscript.

Competing interests

The authors declare that they have no competing interests.

Use of Artificial Intelligence (AI)

The authors declare that they did not use generative AI to come up with new ideas for their review.

يمكنك كتابة تعليق على مراجعة PREreview هذه لـ Combination Therapy in Hypertension: Renin-Angiotensin-Aldosterone System Inhibitor with a Diuretic or Calcium Channel Blocker.

قبل أن تبدأ

سنطلب منك تسجيل الدخول باستخدام ORCID iD الخاص بك. وإذا لم يكن لديك ORCID iD، يمكنك إنشاء واحد.

ما هو معرّف ORCID iD؟

ORCID iD هو معرّف فريد يميّزك عن جميع الأشخاص الذين يحملون الاسم نفسه أو اسمًا مشابهًا.

ابدأ الآن